These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6786322

  • 1. Calculating the dose of factor VIII in the management of haemophilia.
    Ingram GI.
    Br J Haematol; 1981 Jun; 48(2):351-4. PubMed ID: 6786322
    [Abstract] [Full Text] [Related]

  • 2. Lyophilized cryoprecipitate for children with hemophilia A.
    Nuchprayoon I, Sahasittiwat S, Kittikalayawong A, Chantanakajornfung A.
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S293-7. PubMed ID: 12188426
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of methods of plasma volume determination for dose calculation of factor VIII in patients with classic haemophilia.
    Ockelford PA, Lowe G, Johns AS, Berry EW.
    N Z Med J; 1986 Feb 26; 99(796):116-9. PubMed ID: 3081842
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS, Manco-Johnson M, Santagostino E, Ljung R.
    Haemophilia; 2004 Oct 26; 10 Suppl 4():97-104. PubMed ID: 15479380
    [Abstract] [Full Text] [Related]

  • 10. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P, Plamenová I, Hollý P, Stasko J.
    Med Sci Monit; 2009 Jun 26; 15(6):CS105-11. PubMed ID: 19488019
    [Abstract] [Full Text] [Related]

  • 11. Changing pattern of care of boys with haemophilia in western European centres.
    Chambost H, Ljung R, Pednet Group.
    Haemophilia; 2005 Mar 26; 11(2):92-9. PubMed ID: 15810909
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparison of factor VIII infusion methods.
    Cox M, Smith J, Miller R, Pasi J.
    Nurs Times; 2005 Mar 26; 91(49):38-9. PubMed ID: 8552500
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Response of factor VIII/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII).
    Garcia VV, Silva IA, Borrasca AL.
    Thromb Haemost; 1982 Aug 24; 48(1):91-3. PubMed ID: 6813999
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Factor VIII half-life and intensity of treatment in hemophilic patients.
    Vicente V.
    Haematologica; 2005 Apr 24; 90(4):437. PubMed ID: 15820932
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Suppression of inhibitors in haemophilia with corticoids and factor VIII.
    Aznar JA, Jorquera JI, Peiro A.
    Thromb Haemost; 1983 Jun 28; 49(3):248. PubMed ID: 6410535
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.